Penn State sues insulin makers and PBMs alleging inflated prices and seeks damages for overpayments in its self-insured health plans.
The Labor Department’s Employee Benefits Security Administration proposed regulation Jan. 29 that would require pharmacy benefit managers to disclose their compensation with self-insured group health ...
In a new lawsuit, Iowa Attorney General Brenna Bird alleges 18 companies have charged Iowans too much for insulin and ...
The U.S. Department of Labor's Employee Benefits Security Administration on Thursday issued a proposed rule aimed at ...
WJAC-TV on MSN
Penn State sues insulin makers, alleging conspiracy to inflate drug prices by over 1,000%
The Pennsylvania State University has filed a federal lawsuit accusing major insulin manufacturers and pharmacy benefit ...
Penn State is suing a number of major insulin makers and other large health care companies, alleging they participated in an ...
CMS's proposed 0.09% Medicare Advantage rate hike for 2027 triggered a sharp sell-off across US health insurers, signaling ...
HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...
The reason? CVS is more diversified—they operate retail pharmacies (9,000 locations), Pharmacy Benefit Management (CVS ...
Congress may be about to make long-sought changes to pharmacy benefit managers' business practices — though the impact on ...
A House committee found that CVS Health may have violated federal antitrust laws by threatening independent pharmacies to keep them from using money-saving services outside the company's pharmacy ...
The company’s massive pharmacy benefit manager changed its rules and weaponized audits to ensure independent pharmacies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results